Mark Y. Chan
Impact in
- Geriatrics and Gerontology top 0.5%
- Frailty in Older Adults
-
- Acute Myocardial Infarction Research
- Antiplatelet Therapy and Cardiovascular Diseases
- Atrial Fibrillation Management and Outcomes
Papers in
-
- Acute Myocardial Infarction Research 51
- Antiplatelet Therapy and Cardiovascular Diseases 30
- Atrial Fibrillation Management and Outcomes 20
- Heart Failure Treatment and Management 16
- Surgery 58
- Coronary Interventions and Diagnostics 29
- Co-authors
- Ching‐Hui Sia (70 shared papers)Wee Shiong Lim (31 shared papers)Chi‐Hang Lee (62 shared papers)Huay Cheem Tan (66 shared papers)Irene M. Y. Woon (1 shared paper)Atreyi Kankanhalli (1 shared paper)Nicholas Chew (53 shared papers)Adrian F. Low (51 shared papers)
- Journals
- Journal of the American College of Cardiology (14 papers)European Heart Journal (13 papers)International Journal of Cardiology (11 papers)Frontiers in Cardiovascular Medicine (9 papers)Journal of Thrombosis and Thrombolysis (9 papers)
- Partner nations
- SingaporeUnited KingdomUnited States
In The Last Decade
Mark Y. Chan
328 papers receiving 6.1k citations
Mark Y. Chan's Hit Papers
Peers
Comparison fields: 5 of 160
- Geriatrics and Gerontology 299
- Cardiology and Cardiovascular Medicine 1.6k
- Internal Medicine 163
- Endocrinology, Diabetes and Metabolism 499
- Epidemiology 680
Countries citing papers authored by Mark Y. Chan
This map shows the geographic impact of Mark Y. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Y. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Y. Chan more than expected).
Fields of papers citing papers by Mark Y. Chan
This network shows the impact of papers produced by Mark Y. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Y. Chan. The network helps show where Mark Y. Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark Y. Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 349 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 231 | |
| 2 | Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals Hit paper breakdown → | 2022 | 201 |
| 3 | 2009 | 184 | |
| 4 | An Observational Data Meta-analysis on the Differences in Prevalence and Risk Factors Between MAFLD vs NAFLD Hit paper breakdown → | 2021 | 174 |
| 5 | Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium Hit paper breakdown → | 2022 | 172 |
| 6 | 2015 | 116 | |
| 7 | 2008 | 110 | |
| 8 | 2020 | 105 | |
| 9 | 2017 | 101 | |
| 10 | 2008 | 101 | |
| 11 | 2011 | 91 | |
| 12 | 2008 | 88 | |
| 13 | 2017 | 85 | |
| 14 | 2018 | 83 | |
| 15 | 2015 | 83 | |
| 16 | 2010 | 78 | |
| 17 | 2018 | 70 | |
| 18 | Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference for Patients With Obesity or Overweight: A Systematic Review, Meta-analysis, and Meta-regression of 47 Randomized Controlled Trials Hit paper breakdown → | 2025 | 69 |
| 19 | 2020 | 62 | |
| 20 | 2022 | 62 |
About Mark Y. Chan
Mark Y. Chan is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Epidemiology, Endocrinology, Diabetes and Metabolism and Molecular Biology, having authored 349 papers that have together received 6.3k indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (51 papers), Antiplatelet Therapy and Cardiovascular Diseases (30 papers), Coronary Interventions and Diagnostics (29 papers), Cardiac Imaging and Diagnostics (21 papers), Atrial Fibrillation Management and Outcomes (20 papers), Diabetes Treatment and Management (16 papers), Heart Failure Treatment and Management (16 papers) and Liver Disease Diagnosis and Treatment (13 papers). The work is most often cited by research in Geriatrics and Gerontology (299 citations), Cardiology and Cardiovascular Medicine (1.6k citations), Internal Medicine (163 citations), Endocrinology, Diabetes and Metabolism (499 citations) and Epidemiology (680 citations). Mark Y. Chan has collaborated with scholars based in Singapore, United Kingdom and United States. Frequent co-authors include Ching‐Hui Sia, Wee Shiong Lim, Chi‐Hang Lee, Huay Cheem Tan, Irene M. Y. Woon, Atreyi Kankanhalli, Nicholas Chew, Adrian F. Low, Richard C. Becker and Cheng Han Ng. Their work appears in journals such as Journal of the American College of Cardiology, European Heart Journal, International Journal of Cardiology, Frontiers in Cardiovascular Medicine and Journal of Thrombosis and Thrombolysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.